Payal Lakhani


Bio

Payal Lakhani is Director of Equity Research and Product Development at CME Group.

What The 2020 Russell Recon Tells the Market

The newly rebalanced Russell U.S. Indexes took effect on June 29.  Russell reconstitution is a closely watched annual market event…

Why ESG is Outperforming the S&P 500

Over the past year, the S&P 500 ESG Index exhibited returns nearly 3% above the benchmark S&P 500. This is…

Bitcoin Halving Could Be Different This Time Around

The programmed supply reduction could potentially bring a supply shock and large price implications.